| abstract |
The teachings herein relate to combinations of therapeutic agents for use in treating patients suffering from cancer, wherein the combinations include at least one multifold inducer and at least one Bcl-2 family protein inhibitor. In addition, the teachings herein also relate to diagnostic tests useful in the classification of patients for treatment with one or more therapeutic agents. |